News & Articles

Compounded oral chemotherapy plays a vital role in veterinary oncology—particularly when commercial drugs aren’t available or when precise, individualized dosing is required. However, concerns persist about the accuracy and consistency of compounded formulations, which significantly impacts patient outcomes.   Our recent study, published in Veterinary and Comparative Oncology (DOI: 10.1111/vco.13003

Stokes Pharmacy’s exclusive partnership with the Bova Group to bring safe, compounded treatment for feline infectious peritonitis (FIP) to the US brought a lot of excitement for veterinarians and pet owners looking to save cats with FIP. Not having access to treatment previously, Stokes’ release of Bova GS-441524 tablets was the first

Stokes Pharmacy and Bova Partner Up to Treat FIP Stokes Pharmacy, a leading veterinary compounding pharmacy, announces an exclusive partnership with the Bova Group to offer a U.S.-made oral treatment for FIP, or Feline Infectious Peritonitis. Veterinarians will now be able to manage this once-fatal virus with Stokes Pharmacy’s compounded